State-of-the-Art First-Line Treatment of Ovarian Cancer

Publisher： Karger

E-ISSN： 2296-5262|26|5|446-450

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.5, 2003-11, pp. : 446-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First-Line Chemotherapy in Advanced Ovarian Cancer: State of the Art and Future Aspects

By  

Oncology Research and Treatment, Vol. 22, Iss. 4, 1999-09 ,pp. : 269-280

Karger

Access to resources Recommend Favorite

Sequential Combination of Paclitaxel-Carboplatin and Paclitaxel-Liposomal Doxorubicin as a First-Line Treatment in Patients with Ovarian Cancer

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 348-353

Karger

Access to resources Recommend Favorite

Irinotecan (CPT-11) and Cisplatin as First-Line Chemotherapy for Advanced Ovarian Cancer

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 16-22

Karger

Access to resources Recommend Favorite

Dose Finding Study for Combination Treatment with Topotecan and Gemcitabine of Patients with Recurrent Ovarian Cancer after Failure of First-Line Chemotherapy with Paclitaxel and Platinum

By  

Oncology Research and Treatment, Vol. 27, Iss. 1, 2004-03 ,pp. : 58-64

Karger

Access to resources Recommend Favorite

Topotecan in the First-Line Treatment of Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-05 ,pp. : 13-17

Karger

Access to resources Recommend Favorite